Recent Headlines
Temperatures Are Rising – It's Time to Check Your Cooling Towers
As Texas and other parts of the country start to heat up, cooling towers will be in full use. Hyperion Biotechnology offers Legionella testing to monitor for bacteria growth to help reduce the risk of spread from cooling towers. - April 21, 2021 - Hyperion Biotechnology, Inc.
The NIDCAP Federation International Releases a Podcast Series Called NICU Care with NIDCAP, Following World NIDCAP Day 2021
The NIDCAP Federation International releases a podcast series called NICU Care With NIDCAP following the celebrations of World NIDCAP Day 2021. In each episode, best practices are discussed to support the health and development of hospitalized newborns, infants and their families, and those that care for them, in intensive care nursery settings and beyond. - April 17, 2021 - NIDCAP Federation International
New Chief Information Security Officer Named at Lifelines Neuro
Rafael Garrido brings cloud security expertise for expansion of Rendr Platform EEG software. - April 15, 2021 - Lifelines Neuro
Y-Biologics & Pierre Fabre: Confirmation of Research Partnership in Oncology
Y-Biologics and Pierre Fabre confirm their research collaboration for the development of new immunotherapies in oncology. - March 31, 2021 - Pierre Fabre
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
Zifo RnD Solutions Bags the Fastest Growing Company Award at Deloitte Technology Fast 50 2020
Zifo RnD Solutions has been featuring in this list since 2012 and is the only company in India to have won this award 9 years in a row. - March 15, 2021 - Zifo
Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations
Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021 - Intrinsic Imaging, LLC
AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
Phase One Development of Rapid COVID-19 Point of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.
Collection Services Provide Peace of Mind in Fight Against Legionella Bacteria
Hyperion Biotechnology expands Legionella water collection services in several California cities and other U.S. locations. Facility owners can schedule services to support their water safety plans. - February 11, 2021 - Hyperion Biotechnology, Inc.
Cayman Adds Nordic BioSite as Trusted Distributor
Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company
14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.
A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions
Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology
How COVID-19 Has Impacted Academic Research
Dr. Peter Mallow, director, health economics and clinical outcomes research and assistant professor at Xavier University, shares his thoughts on the effect of COVID-19 on the health research community. - November 30, 2020 - Journal of Health Economics and Outcomes Research
Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.
Few people are able to take a COVID-19 test every day or even every week or month. A negative result can be useful on the day of the test, but a person will not know if infected later. The COVID-19 HealthMeter™ reduces that risk with daily noninvasive physiological self-monitoring of 16 COVID-19 indicators and risk factors, including functional age vs. birth age, high frequency hearing loss, mental confusion, short term memory, lungs, blood oxygen, heart rate, blood pressure, body fat, etc. - November 12, 2020 - Centers for Age Control Inc.
Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient
Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO
New Rapid COVID-19 Point of Care Test
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.
Presence of CDC Risk Factors Associated with Increased Risk of Death from COVID-19
New JHEOR research on hospitalized COVID-19 patients with multiple Centers for Disease Control risk factors were significantly more likely to die. - November 07, 2020 - Journal of Health Economics and Outcomes Research
Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D
Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company
3 Steps to Take Now to Reduce the Risk of Legionella in a Building’s Water System
After shutdowns due to coronavirus, businesses are reopening and there are steps building owners can take to check the water safety of their buildings. Hyperion provides Legionella water testing to help businesses reduce the risk of Legionella. - November 01, 2020 - Hyperion Biotechnology, Inc.
Monitor COVID-19 Risk with New Audio and Video Guided Panel of 16 Immediate Non-Invasive Test Results from Centers for Age Control Inc.
The HealthMeter™ COVID-19 Tests (healthmeter.net) enable immediate discovery of potential infection or need for immediate emergency care, noninvasively monitoring a panel of audio and video guided tests of 16 COVID-19 indicators and risk factors, including functional age vs birth age, high frequency hearing loss, mental confusion, lungs, blood oxygen, heart rate, obesity, blood pressure, heart rate. Built on the global cloud based AgeMeter® Functional Age Test for longevity therapy and research. - October 30, 2020 - Centers for Age Control Inc.
The Journal of Health Economics and Outcomes Research Now Fully Indexed in PubMed
The Journal of Health Economics and Outcomes Research (JHEOR) is now fully indexed in PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=J+Health+Econ+Outcomes+Res JHEOR is an international high-quality journal covering all fields and methodologies related to health economics and outcomes research. - October 30, 2020 - Journal of Health Economics and Outcomes Research
ReproTech, Ltd. Presents Study on Important Considerations for Safe Cryogenic Shipping
ReproTech, Ltd. was honored to present an oral abstract at the virtual American Society for Reproductive Medicine (ASRM) 2020 Scientific Congress and Expo that resulted from a study designed by authors, W. Brent Hazelrigg, President and CEO; and Amy Erickson Hagen, Vice President of Quality... - October 29, 2020 - ReproTech, LLC
Artificial Intelligence Search Technology Will be Used to Help Modernize US Federal Pathology Facility
Technology developed by Canadian researchers has been adopted by the Joint Pathology Center (JPC), which has the world’s largest collection of preserved human tissue samples. The v=center will use an artificial intelligence (AI) search engine to index and search its digital archive as part of a modernization effort. The image search engine was designed by researchers at the Laboratory for Knowledge Inference in Medical Image Analysis (Kimia Lab) at the University of Waterloo. - October 28, 2020 - Kimia Lab, University of Waterloo
Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit
The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed & produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators & controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers & healthcare providers access to quantitative patient data in order to better understand a patient's current disease stage. - October 14, 2020 - Epitope Diagnostics, Inc.
ReproTech, Ltd. Celebrates 30 Years in Reproductive Cryostorage
ReproTech, Ltd. is celebrating 30 years as the first company dedicated solely to long-term reproductive tissue storage. Over three decades, ReproTech has expanded from one facility in St. Paul, MN to four regional locations in the United States including Fort Lauderdale, FL; Reno, NV; and... - October 14, 2020 - ReproTech, LLC
Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing
Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.
Cayman Receives SBIR Grant for Alzheimer’s Research
The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. - October 10, 2020 - Cayman Chemical Company
Legionnaires’ Disease Cases Lead to Legionella Water Testing
Hyperion Offers Testing to Identify If Legionella Bacteria Are Growing in a Building’s Water System. - October 03, 2020 - Hyperion Biotechnology, Inc.
Joint Venture Announcement of ECLEVAR and QUINTEN forming ECLEVAR MedTech
ECLEVAR and QUINTEN announced today the formation of the joint venture ECLEVAR MedTech, a medical device contract research organization (CRO) specializing in regulatory compliance and real world evidence post-market solutions. Driven by its innovative data science and machine learning... - October 01, 2020 - ECLEVAR MedTech
Hemanext to Present New Red Blood Cell Research Data at AABB 2020
Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs. - September 29, 2020 - Hemanext
Dr. Michael Epitropoulos' Position of Chief Scientific Officer at HAPInss Brands LLC
In the newly formed position of Chief Scientific Officer, Dr. Epitropoulos will lead evidenced-based research efforts across the entire HAPInss Brands portfolio of products. - September 23, 2020 - AmpLIFEi International
Ampersand Capital Partners Acquires American Laboratory Products Company
American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the... - September 21, 2020 - ALPCO
Testing is the Only Way to Confirm Water is Not Contaminated with Legionella Bacteria
Hyperion Biotechnology is offering complimentary Legionella water testing to local schools in San Antonio, Texas. - September 17, 2020 - Hyperion Biotechnology, Inc.
Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS
A novel discovery from scientists at the ALS Therapy Development Institute (ALS TDI) is the first to indicate that asymmetric di-methylation of arginine could be a promising target for ALS therapies. - September 09, 2020 - ALS Therapy Development Institute
Paras Biopharmaceuticals Finland Oy Joins PSL Alliance and Its Global Membership to Promote Worldwide Reach Out for Paras’ Bioprocess Enzymes
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is pleased to announce that it is now a member of the Pivotal Scientific Limited (PSL) Alliance, a network of companies operating within the biotechnology market. As part of the Company’s portfolio of microbial products, technologies and... - September 08, 2020 - Paras Biopharmaceuticals Finland Oy
Zifo RnD Solutions Partners with Aurigene Discovery Technologies for a Phase III Oncology Trial
Zifo RnD Solutions will be the Data Management Service provider for Aurigene Discovery Technologies’ large data driven Phase III oncology trial. - September 06, 2020 - Zifo
St. John’s to Host Virtual Dribble for the Cure on Sept. 26
Red Storm men’s and women’s basketball teams to support Pediatric Cancer Research Foundation. - September 05, 2020 - Pediatric Cancer Research Foundation
New eClinical Platform Strategic Analysis & Competitive Landscape Report
Survey Quantifies eClinical Platform Use and Satisfaction and Identifies Dramatic Perceptual Changes - August 26, 2020 - Life Science Strategy Group, LLC
AmpLIFEi International(TM) Launches "Travopoly" the Premier Member-Only Booking Engine for the Benefit of VIP Members
Robert Oblon Fulfills Promise to AmpLIFEi(TM) VIP members adding the first VIP Lifestyle service - Travopoly.com. - August 26, 2020 - AmpLIFEi International
Grants Available for Undergraduate Students Seeking Research Experience
Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020, for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants. - August 19, 2020 - Cayman Chemical Company
Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthesis Expertise
Cayman and GenScript have come together to create a complete package of neoantigen discovery services. Through combined efforts, MHC-associated peptides are identified and verified as immunogenic to guide peptide synthesis for vaccine development. “Cayman provides a complete workflow enabling... - August 15, 2020 - Cayman Chemical Company
Harmful Bacteria May be Growing in a Building’s Water During COVID-19 Shutdowns
Legionella Water Testing Kits can help Businesses Reopen Safely. Hyperion Biotechnology now provides everything building owners need to collect samples for laboratory analysis to determine if Legionella bacteria are present. - August 15, 2020 - Hyperion Biotechnology, Inc.
UCLA and the Pediatric Cancer Research Foundation (PCRF) Kick Off Annual “Dribble for the Cure” with Urgent Call for Public to Help Save Lives of Children with Cancer
An annual event that raises money for children's cancer research is going virtual. - August 12, 2020 - Pediatric Cancer Research Foundation
Help for Hotels as They Reopen - Hyperion Biotechnology Offers Legionella Water Testing
Hotel owners can test water systems to ensure guests’ safety from exposure to Legionella, a bacteria that can cause Legionnaires’ disease when spread through mist from a hotel’s water system. - August 07, 2020 - Hyperion Biotechnology, Inc.
Amplifei International Given Approval to Market HAPInss Brands' New “Hemplifei” CBD Products
Through its exclusive marketing agreement, Amplifei will now offer The Hemplifei™ products with an advanced breakthrough in Endocannabinoid Nutrition (ECN). - August 06, 2020 - AmpLIFEi International
Los Angeles-Area Clinic to Offer Free Rapid and Accurate COVID-19 Testing to LAPD and LASD Officers
Near-immediate testing results will give frontline law enforcement officers peace of mind as they both work within the community and return safely to their families. - July 29, 2020 - Thrive Medical
Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.